Common Contracts

EX-10.46 8 d681079dex1046.htm EX-10.46 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under Execution Version AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT FOR THE UNITED...

Collaboration and License Agreement • May 5th, 2020 • New York

• Contract Type
  Collaboration and License Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

THIS AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT FOR THE UNITED STATES (the “Agreement”) is made and entered into as of November 18, 2013 (the “Amended and Restated Execution Date”), by and between POZEN INC., a Delaware corporation having offices at 1414 Raleigh Road, Suite 400, Chapel Hill, North Carolina (“POZEN”), and ASTRAZENECA AB, a Swedish corporation having an office at SE-431 83, Mölndal, Sweden (“Licensee”). POZEN and Licensee each may be referred to herein individually as a “Party,” or collectively as the “Parties.”

AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT FOR THE UNITED STATES by and between POZEN INC. and ASTRAZENECA AB November 18, 2013

Collaboration and License Agreement • May 23rd, 2014 • Horizon Pharma, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Collaboration and License Agreement
• Filed
  May 23rd, 2014
• Company
  Horizon Pharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT FOR THE UNITED STATES (the “Agreement”) is made and entered into as of November 18, 2013 (the “Amended and Restated Execution Date”), by and between POZEN INC., a Delaware corporation having offices at 1414 Raleigh Road, Suite 400, Chapel Hill, North Carolina (“POZEN”), and ASTRAZENECA AB, a Swedish corporation having an office at SE-431 83, Mölndal, Sweden (“Licensee”). POZEN and Licensee each may be referred to herein individually as a “Party,” or collectively as the “Parties.”

AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT FOR THE UNITED STATES by and between POZEN INC. and ASTRAZENECA AB November 18, 2013

Collaboration and License Agreement • March 13th, 2014 • Horizon Pharma, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Collaboration and License Agreement
• Filed
  March 13th, 2014
• Company
  Horizon Pharma, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT FOR THE UNITED STATES (the “Agreement”) is made and entered into as of November 18, 2013 (the “Amended and Restated Execution Date”), by and between POZEN INC., a Delaware corporation having offices at 1414 Raleigh Road, Suite 400, Chapel Hill, North Carolina (“POZEN”), and ASTRAZENECA AB, a Swedish corporation having an office at SE-431 83, Mölndal, Sweden (“Licensee”). POZEN and Licensee each may be referred to herein individually as a “Party,” or collectively as the “Parties.”